Information Provided By:
Fly News Breaks for February 25, 2020
METC, SONO, CLVS, WIX, CUE
Feb 25, 2020 | 10:15 EDT
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cue Biopharma (CUE) initiated with an Outperform at Oppenheimer. 2. Wix.com (WIX) initiated with a Buy at Needham. 3. Clovis (CLVS) initiated with an Outperform at RBC Capital. 4. Sonos (SONO) initiated with a Neutral at BofA. 5. Ramaco Resources (METC) initiated with a Buy at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
News For CUE;WIX;CLVS;SONO;METC From the Last 2 Days
CLVS
Feb 23, 2021 | 11:10 EST
Piper Sandler analyst Joseph Catanzaro raised the firm's price target on Clovis to $5.75 from $5.00. Clovis reported Q4 earnings with Rubraca revenues of $43.3M, in-line with the earlier pre-announcement, and while no guidance for 2021 was provided, Catanzaro expects growth in 2021 to be consistent with that of 2020 given the steady market share in ovarian, continuing launch in the EU and headwinds faced in prostate, the analyst tells investors in a research note. Catanzaro maintains a Neutral rating given continued concerns around cash/debt position on the background of an uninspiring near-term Rubraca growth trajectory.
METC
Feb 23, 2021 | 08:32 EST
B. Riley Securities analyst Lucas Pipes raised the firm's price target on Ramaco Resources to $9 from $8 and reiterates a Buy rating on the shares. With Ramaco "returning to growth mode," the company laid out a path to achieving its longer-term goal of 4.0-4.5M tons of annual production in the coming years, Pipes tells investors in a research note.